{ }
Glaukos Corporation specializes in ophthalmic pharmaceuticals and medical technologies, focusing on innovative therapies for glaucoma, corneal disorders, and retinal diseases. The company develops microinvasive devices to lower intraocular pressure and offers various drug delivery systems, including transdermal pharmaceuticals and sustained-release implants, aimed at enhancing patient vision and managing ocular conditions.
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology firm, focuses on innovative, drop-free therapies for glaucoma, corneal, and retinal diseases. Its offerings include microinvasive glaucoma surgery devices and sustained-release pharmaceutical products that effectively lower intraocular pressure and enhance vision. The company also develops transdermal drugs for various ocular conditions.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.